Meeting
2019 ASCO Annual Meeting
A donor-dependent in vivo model for single agent and drug combination cytokine release syndrome safety evaluation.
Authors
James G. Keck
The Jackson Laboratory, Sacramento, CA
James G. Keck , Mingshan Cheng , Michael Brehm , Dale Greiner , Lenny J. Shultz , Jens Rueter , Chunting Ye
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Immunotherapy and Tumor Immunobiology
Track
Developmental Therapeutics—Immunotherapy
Sub Track
New Targets and New Technologies (IO)
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2612)
DOI
10.1200/JCO.2019.37.15_suppl.2612
Abstract #
2612
Poster Bd #
256
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
An in vivo model to evaluate donor-dependent cytokine release in response to single-agent or combination immune-oncology therapies.
First Author: Kyle Draheim
Poster
2023 ASCO Annual Meeting
Identification of cytokines associated with response and cytokine release syndrome: Analysis of MagnetisMM-3 cohort A.
First Author: HANG QUACH
Poster
2024 ASCO Annual Meeting
Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients.
First Author: Rongsu Qi
Poster
2022 ASCO Annual Meeting
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC).
First Author: Giulia Pasello